Skip to content
Open access

m6A depletion attenuates the macrophage type I interferon response

Aug 2026 · bioRxiv · 0 citations · 6 references
Biology

TL;DR

It is found that in THP1-derived and peripheral blood macrophages, m6A depletion with the METTL3 inhibitor STM2457 leads to enhanced proliferation of the human coronavirus OC43 and it is concluded that macrophages depend on m6A to support expression of interferon sensing machinery and in m6A’s absence, fail to mount as strong of a type I interferon response.

Abstract

Macrophages play an important role in coordinating the antiviral response and post-transcriptional regulation of mRNA is an important element of the inflammatory gene expression required for defense against viral pathogens. N6-methyladenosine (m6A) deposition on mRNA by METTL3 constitutes one such post-transcriptional event which facilitates a cascade of downstream regulation via RNA decay and translation. We discovered that in THP1-derived and peripheral blood macrophages, m6A depletion with the METTL3 inhibitor STM2457 leads to enhanced proliferation of the human coronavirus OC43. Using TimeLapse-seq to comprehensively measure changes in abundance, RNA decay and transcription, we find that STM2457 downregulates the interferon response far upstream by reducing expression of both the type I interferon receptor and STAT1. We conclude that macrophages depend on m6A to support expression of interferon sensing machinery and in m6A’s absence, fail to mount as strong of a type I interferon response.

Read PDF

Similar papers

Open access Sep 2026

METTL3 promotes human coronavirus replication through an interferon-independent mechanism

A METTL3-directed Proteolysis Targeting Chimera (PROTAC) phenocopied STM2457, producing IFN-independent antiviral activity and ruling out off-target inhibition of viral RNA methyltransferases as a plausible explanation are defined.

Ikshitaa Dinesh, Joaquim M. G. D. Fonseca, Denise Ohnezeit et al. · 0 citations
Aug 2026

EIF2AK2 inhibits type I interferon production by inhibiting RIG-I activation and disrupting mitochondria function via recruiting VAMP8 and p-MLKL.

It is demonstrated that viral infection induced elevated expression of Eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2), which is an interferon-stimulated gene (ISG) with unclear role in the innate immunity, and its potential as a therapeutic target for controlling dysregulated IFN-I responses is sug...

Qin Chen, Jing-Yi Wu, Fang-Bin Huang et al. · 0 citations
Sep 2026

Mycobacterium tuberculosis Rv3248c Inhibits Type I Interferon Response and Promotes Intracellular Survival by Mediating Ubiquitin-Proteasome-Dependent Degradation of TBK1

Findings identify a previously uncharacterized mechanism by which M. tb dampens the IFN-I response by targeting TBK1, highlighting Rv3248c as a contributor to pathogenesis and a potential therapeutic target.

Zheng-Zhong Xu, Min-Li Geng, Zhi-Fang Zhang et al. · 0 citations
Open access Sep 2026

Mycobacterium tuberculosis Rv0158 negatively regulates the cGAS-STING pathway mediated type I IFN production and enhances intracellular survival.

Overall, the finding identified a new bacterial factor Rv0158, which improves the understanding of the immune evasion mechanisms of M. tb, and suggests that Rv0158 may indirectly facilitate STING degradation or modulate its stability through host-interacting partners.

Zheng-Zhong Xu, Min-Li Geng, Zhi-Hong Yao et al. · 0 citations
Sep 2026

NFKBIB methylation by SETD3 controls NF-κB-mediated interferon activation during viral infection.

The activation and regulation of type I interferon (IFN-I) is essential for the antiviral response and while epigenetic modifiers are known for regulating cellular signaling and responses by modifying nonhistone substrates, their role in IFN-I signaling remains uncertain. Here, through high-throughput screening, we ide...

Rui-Qi Sun, Bo-Xuan Yin, Li-Lin Zhang et al. · 0 citations
Review Open access Aug 2026

Mitochondrial checkpoint for interferon responses in macrophages

A functional immune system is a key antagonist of cancer cell growth. Cytokines such as interferons (IFNs) promote the onset of inflammation, turn cells into an anti-viral state, and shape the dynamic tumor-immune cell interactome. Recent work illustrates how type I IFNs contribute to the resolution of inflammatory con...

Andreas O. Mieland, O. Krämer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.